624
200192226014562121183
PŘEHLEDOVÝ852207016974156235334409485586692777867
ČLÁNEK1757207016989163260360438521
Ces8507936014570127174
Urol10497936014578115180208
2019;12827936014562121176229253
23(3):15607936014562122153211240262
194–20218487936014561114176239294353410
8.85089601335680
Nordstrom954896013373133169230273310345405496
T,147589601335470
Akre1570896013367118155209
O,180489601337695
Aly192489601336792144
M,2092896013389113
et222989601335592
al.234589601335379101
Prostate‑specific247289801315586142182217266299350384425484538587609635662710
antigen3206898013151109141163222275333
(PSA)356389801313084134196224
density3812898013160113171210232265316
in415289801312582
the425889801313593146
diagnostic443089801316081130189247305345380402450
algorithm490489801315173133191223245279337426
of850104801315987
prostate961104801316193149189224273306357
cancer.1342104801314998156205256287301
Prostate1667104801315586142182217267299350
Cancer20411048013162112170219269301
Prostatic,2366104801315586142182217266298321369387
DiS.2777104801317294143162
2018;29631048013154105153199216
21(1):32041048013153100122169189206
57–63.34341048013154104153210261278
9.850119601335675
Bhat9511196013359120173208
NR,11841196013372131156
Vetter13661196013361112148187240276
JM,16651196013343131155
Andriole18451196013367128190225250310336391
GL,22621196013371123146
et2433119601335592
al.2550119601335378101
Magnetic26781198013186135194252305338360408
Resonance31131198013155108148207265314372420471
Imaging‑Defined36081198013125114163223244302361395467520546573630683744
Prostate‑Specific4378119801315585142182216266298349384431490544593615641668716
Anti‑51201198013165123155177210
gen8501348013160113171
Density10441348013171125182222243276328
Significantly1395134801315172131189210236263311361419451473521
Improves19401348013122111171203259307359400
the2364134801313391144
Risk2531134801315578117162
Prediction2716134801315585137197219267303325383442
for3182134801312885117
Clinically3322134801316284106163185233283305327375
Significant3720134801315172131189211236263312361419451
Prostate4194134801315586142182217266298349
Cancer45661348013163113171219270301
on48901348013159117
Biopsy.5030134801315678136196236285299
Urology8501498013169100156179237298346
2018;12201498013154105153200217
18:14611498013153100117
1324–1328.1602149801315499148195252298343392443462
10.8501646013356107129
Catalona10031646013364116152205230290351404
WJ,14301646013394128150
Partin16031646013359110146185210270
AW,18971646013367155173
Slawin2094164601335479132211237297
KM,24151646013359149173
et2612164601335592
al.2727164601335379101
Use28531648013169107160
of3038164801315887
the3149164801313492145
percentage33191648013160115146193244301333383442495
of3839164801315887
free3950164801312962113167
prostate‑specific4142164801316092149189224273305356391431490545594616642668717
antigen48831648013150108140162221274332
to5239164801313490
enhance8501798013153110167215272320370
differentiation1240179801315981109139190221272329360382429461482539597
of1857179801315886
prostate1962179801316092148187221270301352
cancer2333179801314998155203253284
from2640179801312557113202
benign28611798013161114171192251308
prostatic3188179801316092148187221270301323371
disease:3578179801316081119172219258310328
A39251798013164
prospective4009179801316091147187245298347383404453504
multicenter45321798013190146168200222269320377408458489
clinical504117980131487091148169217266287
trial.85019480131346688137159177
JAMA1051194801313899184248
1998;1324194801315398152205222
279:15701948013154103154173
1542–1547.1767194801315398151200252298343396445452
11.8502096013356101118
Vickers994209601336188136187240276320
AJ,13402096013367111132
Savage14972096013354108158211272327
C,1850209601336388
O’Brien1963209601337699159194220275335
MF,23242096013388142154
et2503209601335692
al.2621209601335378100
Systematic2746209801315398139173224313362394416464
review3235209801313486135157210288
of3550209801315887
pretreatment3663209801316193144177209260309341430483541573
prostate4262209801316193150190224274306357
specific46432098013143102156206228254280329
antigen49962098013152110141164223275333
velocity8502248013150102124182232253287338
and12122248013150108167
doubling14032248013160118176236259280338397
time1824224801313456145198
as2046224801315090
predictors2160224801316193144205226275311367399440
for2624224801312986118
prostate2766224801316193149189224273306357
cancer.3147224801314998156205256287301
J34722248013138
Clin3534224801316385106164
Oncol.37222248013174133181237260279
2009;40252248013153105160213232
27:42812248013153103117
398–403.44222248013153104157213269324374392
12.8502396013357105129
Lukeš10032396013360120171225269
M,13032396013390114
Záleský14412396013369123149205248300356
M,18282396013389114
Zachoval19662396013369123173233294346400426
R,2415239601336893
Urban25402396013372107170224285
M,28572396013389114
Heráček30022396013373129165218268322374
J.3400239601334971
Prostatický3495239801316495152193228278311333382428481
specifický40002398013150110164214237263290339385437
antigen44622398013158117149172231285344
a48302398013159
karcinom49132398013155107139186208266325416
prostaty.850254801316193149189224273306357370
Klinická1244254801315580101159180229274325
onkologie15932548013158117162219242300360382435
2001;20522548013153105160208218
14(4):22942548013154100129179204221
114–118.2539254801315494141198244285331350
13.8502696013356105126
Klečka1000269601336693148198248302
J,1325269601334769
Běhounek14172696013366121182242303363418470
P,1910269601336575
Hora20152696013371132168221
M.22662696013388112
Současné24032698013158116174223272312369422
postavení28502698013167126166201250298350408429
PSA33032698013163112175
v35022698013156
diagnostice3582269801316789137197254313353387409458508
karcinomu41152698013153104135182203261319409466
prostaty.46052698013168100156196231280313364377
Urolog.50132698013169100157180238298317
praxi850284801316193143190213
2008;10872848013154105160214231
9(4):1342284801315482132157174
187–189.15402848013154100150198245291343358
14.8502996013356106128
Le10032996013352107
BV,11352996013360119135
Griffi12962996013371107132162192222
n15432996013361
CR,16292996013364122147
Loeb18012996013352111167229
S,2056299601335476
et2157299601335692
al.2274299601335379101
[-2]2399299801313161108133
Proenzyme2558299801315586142196254299350441494
prostate3078299801316193149189224273305356
specific34592998013143102156205227253280328
antigen38112998013152110142164223276334
is4169299801312564
more42592998013190149181232
accurate45152998013152101147205236286318369
than4908299801313694143201
total5133299801313692124174196
and8503148013150108167
free1041314801312861113166
prostate1230314801316193150190224274306357
specific1611314801314099153203225250277326
antigen19603148013150107139161220273331
in2315314801312280
differentiating2418314801316082111140192224275333365387435468490547607
prostate3048314801316092149189223273305356
cancer3427314801314999157205256288
from3739314801312861117207
benign39693148013161115173194253311
disease4303314801316082121174222262315
in4642314801312279
a47443148013150
prospective4818314801316092149189248302351388410459511
prostate850329801316193149189224273306357
cancer1231329801314998156205256287
screening1542329801314190121173227285306364423
study.1989329801314176134193241255
J22683298013138
Urol.2330329801316999156179198
2010;25523298013153105153200218
183:27943298013154100152167
1355–1359.2985329801315499148197252299343393441457
15.8503446013356103122
Mikolajczyk9893446013388112161218243293318365412465515
SD,15213446013354124142
Millar16803446013388112135159209243
LS,19403446013352105126
Wang20833446013392141199259
TJ,2359344601335486106
et2482344601335590
al.258934460133527697
A27043448013164
precursor2786344801316090140188243273312369399
formof3208344801312479109197273300
prostate‑specific3526344801316090145184217264295344377416473525573593618644691
antigen42353448013149105136156213265321
is4578344801311856
more46513448013190146177227
highly4895344801315979136192213259
ele‑5172344801315374125158
vated850359801314997128177236
in1108359801311874
prostate1199359801316091145184216264295344
cancer1561359801314896152199248278
compared18563598013149103191248296326376434
with2308359801317899131187
benign25133598013160112168189246302
transition2837359801312959107163201220252273329385
zone3240359801314498155206
prostate3464359801316090145183216264295344
tissue.383035980131295087125180231247
Cancer40953598013162110166213262291
Res.44043598013155106145163
2000;45843598013154103157210227
60:48283598013153105123
756–759.49683598013153101151207253300347361
16.8503746013356107130
Mikolajczyk10073746013388114165223249302327376425480532
SD,15623746013358130149
Rittenhouse1738374601335985121160214274335395455498553
HG.23183746013372143167
Pro2510374801315990146
PSA:26803748013160109172191
a28953748013154
more29773748013190149181232
cancer32333748013153103161210260292
specific35493748013145104158208229255282330
form3903374801313390122212
of4144374801315886
prostate4259374801316092149189223273305356
specific46393748013145104158208230256282331
antigen49943748013154111143165224277335
for850389801312986118
the992389801313492145
early11613898013154102133156204
detection13893898013160113146197246282304362421
of1834389801315887
prostate1945389801316193149189224273305356
cancer.2325389801315099157206256288302
Keio26513898013155107129186
J28613898013138
Med.29233898013186139199218
2003;31653898013154106161211226
52,34153898013154104122
86–91.35613898013154107165218266278
17.8504046013356101111
Jansen978404601334191150190244303
FH,12974046013354121142
van14564046013353104162
Schaik16354046013354102160210234283
RH,19354046013358128150
Kurstjens21024046013359116149192227250303362403
J.2522404601334060
Prostate‑specific2601404801315584138177210257288337370409466518566586611637684
antigen33024048013150106136156214265321
(PSA)3645404801312476124185211
isoformp2PSA3879404801311755111138193223311389437488536596
in4498404801311773
combination45884048013149103191249270325372403423479536
with51414048013179100132188
total850419801313489120168189
PSA10574198013155104165
and12404198013149106164
free1427419801312455106158
PSA16034198013155104165
improves17904198013118106164195250297347386
diagnostic2194419801316081128186242299338371392439
accuracy2651419801315097142198228277324374
in3048419801311874
prostate3140419801316091146185218267298347
cancer3505419801314998154201251281
detection.38044198013160111143193241276297353410429
Eur42514198013151105135
Urol.4404419801316898153175192
2010;46144198013154104150196213
57:48454198013154103115
921–927.49784198013154103148196248296345351
18.8504346013356107130
Guazzoni10054346013371131184231281340401426
G,1456434601337195
Nava15764346013372125176228
L,1829434601335275
Lazzeri19294346013352106153203258293319
M,22734346013388112
et2410434601335591
al.2526434601335378101
Prostate‑specific2652434801315586142182217266299350384425484538587609635662710
antigen33864348013151109141163222275333
(PSA)3743434801313084134197224
isoform3992434801312463121149207239329
p2PSA43464348013161111163213275
significantly4645434801314264123180202228255303353411442465513
im‑51824348013124113147
proves850449801316193149198249290
the1164449801313997150
prediction1343449801316193144205227275311333391449
of1822449801315886
prostate1938449801316092149189224273305356
cancer23184498013155104162211262293
at2635449801315587
initial2746449801312986108141163211234
extended30044498013158106143193251311364424
prostate3457449801316193150190224274306357
biopsies3843449801316183141201241263315355
in4223449801312885
patients43384498013160110142164217275307348
with47164498013179102135193
total4933449801313995128177199
PSA51574498013160110172
between8504648013161115148229282335393
2.01267464801315472125
and14164648013150108167
1016074648013154101
ng/ml:17274648013159119158244267284
results2035464801313284124180202236277
of2336464801315987
a24474648013150
prospective2521464801316193150190249303352389411460512
study3057464801314175133192241
in3322464801312380
a34264648013150
clinical350146480131497192150171220269292
setting.3817464801314194127163185243302321
Eur41624648013151107138
Urol.43244648013169100156179198
2011;45464648013153105153193204
60:47744648013154108126
214–222.49244648013154101148205252305357375
19.8504796013357106125
Catalona10064796013364117152206231291353405
WJ,14424796013393128150
Partin16154796013366118153193217278
AW,19244796013367156174
Sanda21214796013362116176238291
MG,24434796013388159183
et2650479601336299
al.2772479601336187109
A29064798013173
multicenter30114798013190147169203225273324382414465497
study3532479801314984142201250
of3806479801316695
[-2]pro‑prostate3925479801313768114140198231287322383416472512547597629680
specific46294798013149109163213234260287336
antigen49894798013158116148170229282340
combined8504948013149105195254277334387448
with13204948013180102135194
prostate1536494801316193149189224273306357
specific1917494801313998152202223249276324
antigen22644948013150108139161221273331
and26184948013150107167
free2809494801312760112165
prostate2997494801316193149189224273305356
specific3377494801314099153203224250277325
antigen37254948013150107139161220273331
for4080494801312785117
prostate4219494801316193149189224273306357
cancer4598494801314999157205256287
detection49084948013160113146197246282304362421
in850509801312381
the955509801313492145
2.01124509801315471124
to1273509801313389
10.013875098013153100118171
ng/ml15785098013158118157243266
prostate1868509801316092149189224273305356
specific22485098013141101155204226252278327
antigen25995098013150108139162221274331
range.2954509801313383141200253270
J32485098013138
Urol.33105098013169100156179198
2011;35325098013154105153194204
185(5):37605098013154100152177228255272
1650-1655.40565098013153100151203239285331382431448
20.8505246013356111133
Lazzeri10075246013352106154203258294319
M,13505246013389113
Haese14875246013372125180223278
A,1789524601336792
de19055246013362117
la2046524601332779
Taille21495246013355100125150175230
A,2403524601336892
et2520524601335591
al.2636524601335378100
Serum27625248013151104136194283
isoform3069524801312463121149207239329
[-2]3422524801313060106132
proPSA3579524801316193149204254316
derivatives39205248013160113144167216266298320370422462
signifi4406524801314263122180202228254
cantly46845248013151100158190212260
improve49685248013124113173205261309361
prediction850539801316193144205226275311333391449
of1323539801315987
prostate1434539801316193149189224274306357
cancer1815539801314999156205256287
at2126539801315082
initial2233539801312380102135157205228
biopsy2485539801316083141201241290
in2799539801312381
a29045398013150
total2978539801313490122172194
PSA31965398013156105168
range3388539801313282140199252
of3664539801315987
2–1037755398013154106152199
ng/ml:39935398013159118157244266283
a43005398013150
multicentric43745398013190147169203225273324382414445468516
European49145398013152107138195255309357415
study.850554801314176133193241254
Eur11295548013151106137
Urol12905548013169100157180
2013;14945548013153105153197213
63(6):17315548013154105131182208225
986–994.19805548013153106160218271324379396
21.8505696013356107124
Král994569601336097150175
M,11905696013388112
Hradil13225696013372108161223248273
D,1615569601337393
Grepl17285696013371107162224250
M,19985696013389113
et2131569601335592
al.2243569601335378101
Prostate2365569801315586142182217266299350
health27365698013158112160182215273
index3033569801312078137190238
(PHI)3295569801312680147169196
u35125698013159
pacientů35925698013161111159181234291323381
s39975698013138
karcinomem4056569801314697128175197254313402456545
prostaty4622569801316092149189223273305356
a49995698013150
s50735698013138
BPH.51325698013156111177197
Česká8505848013163114154199250
urologie1124584801315890146169227287309362
2011;15105848013154105153194204
15(Suppl1738584801315499124172229288349372
2):213458480131548096
16–68.22545848013154101159215269289
22.8505996013356112135
Klečka1005599601336087142192242296
J,1324599601333859
Hora14045996013371132168221
M,16455996013389113
Topolčan17785996013355108170231257306359419
O,2218599601337695
et2334599601335591
al.2446599601335378100
Je2571599801313588
proPSA2680599801316193150205254317
více3018599801314972120171
specifický3213599801313897151201223249275324369421
marker36555998013190139170216268299
pro3975599801316193150
detekci41465998013160112145196242289311
karcinomu4478599801314797129175197255313403460
prostaty.4959599801316193149189224273305357370
Ces8506148013163114154
Urol10286148013169100156179
2011;12316148013154106153194205
15(Suppl1460614801315398124172228288348371
2):185561480131548097
16–68.19766148013154100158215269288
23.8506296013357113134
Fuchsová10086296013362120169230272333385438
R,1470629601336792
Topolčan15866296013362116179240266315369430
O,2047629601337696
Vrzalova21676296013369103152207232293345398
J,2588629601334971
et26826296013363100
al.2806629601336186109
Přínos2939629801316494117175234274
stanovení3237629801315085134193251300352410432
[-2]proPSA3694629801313767114140199231288343394456
v41756298013158
diferenciální4257629801316890119171203255313362384433455513535
diagnostice4816629801316890139199257316356391413462513
karcinomu850644801314797129175197255313403460
prostaty.1334644801316092149189224273305357370
Ces17286448013163114154
Urol19066448013169100156179
18(1):21106448013153100128175195212
21–25.23466448013154101150198251267
24.8506596013356109131
Čapoun10046596013364117179240300361
O,1387659601337696
Sobotka15066596013354114177238273324378
R,1907659601335984
Soukup20146596013354114175226286348
V,2385659601336177
et2485659601335592
al.2600659601335378100
Prostate2725659801315586142182217266299350
health30986598013159112160182216274
index3396659801312280139192240
(PHI)3660659801312983150172199
v38836598013150
primární3956659801316193116204253285343365
diagnostice4345659801316081130189247305345380402450501
karcinomu4870659801314697128175197254312402459
prostaty.850674801316193149189224273306357370
Ces12446748013163114154
Urol14226748013169100157180
2014;16266748013153105153199216
18(Suppl18666748013154100128176233292352375
1):226667480131537390
21–109.23806748013154101150197244297312
25.8506896013356112133
Vickers1007689601336188137187241276320
AJ,13516896013368111132
Cronin1507689601336499158219244305
AM,18366896013367155179
Aus20396896013368126169
G,2232689601337195
et2351689601335591
al.2466689601335379101
A25926898013164
panel26816898013161111169222244
of2950689801315887
kallikrein3061689801314798120142163209242293315373
markers34596898013190139170216268299340
can3823689801315099157
reduce4004689801313385145202251302
unnecessary43306898013159117174227277328368408458489541
biopsy4896689801316183141201241290
for5211689801312986118
prostate850704801316193149189224273306357
cancer:12317048013152102160209259291311
Data15697048013172120152202
from1795704801313366122212
the2031704801313896149
European22047048013155110141198258312360418
Randomized26467048013159109167226284374396440491551
Study3221704801315586144203252
of3501704801315887
Prostate3612704801315989146186220270302353
Cancer39937048013162112170219269301
Screening43187048013155104135186240298320377437
in4779704801312784
Goteborg,48917048013169128160211271330362420438
Sweden.8507198013151127179240293351369
BMC12437198013156141202
Med.14707198013185138199217
2008;17127198013153105160214231
6:1967719801315471
19–24.2062719801315499156203251269
26.8507346013357111134
Stattin1007734601336297150186224249310
P,1340734601336776
Vickers1440734601336996145196249285329
AJ,18017346013367111132
Sjoberg1957734601336287147210266302363
DD,23517346013374147166
et25417346013363100
al.2664734601336187109
Improving27987348013132121181213270318341399459
the32817348013142100154
Specificity34597348013159118173222244270297346368401453
of3936734801316795
Screening40567348013159108140191245304325383443
for4523734801313795127
Lethal46747348013158110143201250272
Prostate4971734801316394151191226275308359
Cancer8507498013163112170219270301
Using11827498013169107128186245
Prostate‑specific1451749801316393150190224274306357391432491545595616642669717
Antigen21997498013165123155177236289346
and25707498013156114174
a27687498013157
Panel28497498013162110168221243
of3116749801316694
Kallikrein32347498013162113135157178224257309330388
Markers:36537498013186135166212264295336354
A40387498013164
Nested41337498013170123164198249310
Case‑Control44747498013162112152205239305361419451483540563
Study.5061749801315889147206254268
Eur8507648013151107138
Urol.10127648013169100156179198
2015;12347648013153105153197212
68(2):14707648013154108136187213230
207–213.17247648013154105154203250297342360